Cell replacement therapy offers new hope for millions of people affected by retinal degenerations (RDs)—a group of blinding conditions caused by the loss of light-sensing photoreceptor cells in the retina. Among the most promising approaches is the transplantation of stem cell-derived partially differentiated photoreceptor cells, known as precursor cells, to replace those lost to disease. But a persistent hurdle remains: Many of the transplanted cells do not survive long enough to integrate or restore vision.
Go to Source
https://medicalxpress.com/rss-feed/